| COUNTRY |
FUNDING BODY |
TYPE OF STUDIES |
AMOUNT AVAILABLE |
DEADLINE |
Austria |
Austrian Science Fund |
Prevention, mitigation, detection, containment of epidemics, including SARS CoV2 and impact of current epidemic |
Not specified |
30-09-2020 |
Czech Republic |
Grant Agency of the Czech Republic, collaboration with Austrian Science Fund – International projects |
As stipulated in the FWF call above, International projects must also focus on: Prevention, mitigation, detection, containment of epidemics, including SARS CoV2 and impact of current epidemic. |
Not Specified |
30-09-2020 |
Czech Republic |
Czech Technology Agency |
Innovative solutions for combating the current epidemic and improving preparedness in future outbreaks |
40 M CZK per project |
31-12-2020 |
France |
National Research Agency (ANR) – “RA-COVID19” |
Operational/interventional studies for prevention or diagnostics, clinical trials, vaccine trials, Epidemiology and surveillance, OneHealth approaches, socio-economic impact studies |
Epidemiology, Physiopathogenesis, Infection prevention and control, Ethics and social dynamics, Global issues of the Covid-19 epidemic. |
28-10-2020 |
France |
BPI France/ Secretariat Général Pour L’Investissement |
Public private partnerships for developing and producing therapeutic solutions for COVID19, including clinical trials |
4M to 50 M € per project |
30-09-2020 |
Germany |
German Research Foundation |
Prevention, early detection, containment and investigation of the causes, impacts and management of epidemics and pandemics including but not exclusively SARS CoV 2 |
Not specified |
Letter of intent: 01-07-2020 / Final submission: 01-09-2020 |
Germany |
Federal Ministry of Education and Research |
Vaccine development and clinical trials |
NA |
31-12-2020 |
Italy |
Lazio Region – Lazio Innova |
Treatment, diagnostics, preventive strategies |
3M € total and 350K €/project |
30-09-2020 |
Malta |
Malta Council for Science and Technology & Malta Enterprise |
Epidemiology, Basic Science, Clinical Research, Social Sciences, IT, |
5,3 M € total |
30-12-2020 |
Spain |
Banco Santander/Crue Universidades Espanolas |
Big data analysis, clinical research, basic science, socio-economic impact, innovative products and solutions for crisis mitigation |
8,5 M € Total |
Rolling applications until 18 December 2020 |
Sweden |
Swedish Research Council |
Exceptional redirection of ongoing grants to focus on COVID19 |
No more than 1/3 of amount yearly allocate |
Ongoing – requires an authorization |
United Kingdom |
British Heart Foundation |
Clinical research on cardiovascular disease and COVID19 |
Not specified – applications must align with UK COVID19 priorisation process |
Rolling applications evaluated weekly |
United Kingdom |
UK MRC |
Virology, Immunity and Pathophysiology, Diagnostics, Epidemiology, PPE and other protective material, Public Health, Clinical Research, Vaccines, Health Care and Delivery |
Variable depending on project needs |
Rolling call - 1 Apr 2021 |
United Kingdom |
NIHR |
Urgent Public Health Research – through National Priorisation Process |
NA |
Rolling applications |
United Kingdom |
NIHR |
Solutions for low and middle-income countries – clinical trials, epidemiology, prevention, diagnostics and more |
1M£/project |
10-08-2020/28-09-2020 |
United Kingdom |
UK Research and Innovation/ Newton Fund |
Innovative solutions to gather critical data, support manufacture or wide scale adoption of an intervention, better understand and mitigate impact of the epidemic in Low and Middle Income countries |
80% of the full economic cost |
none - apply at any time |
United Kingdom |
Action Medical Research |
Paediatric disease, diagnosis, treatment and/or health system policy |
£200,000/project |
25 August intent/29 September |
United Kingdom |
UK Research and Innovation |
Innovative solutions to gather critical data, support manufacture or wide scale adoption of an intervention, better understand and mitigate impact of the epidemic |
80% of the full economic cost |
none - apply at any time |
Pan European |
Partnership for Advanced Computing in Europe (PRACE) |
Projects requesting computer resources for: epidemiology, bioinformatics, bio-simulation, biomolecular analysis, other studies to mitigate the epidemic |
Resources requested reviewed for each proposal |
Open until further notice |
Pan European |
Interreg- Northern Periphery and Arctic Program |
Clinical aspects of COVID19, health and wellbeing of populations during and after the pandemic, technological solutions, citizen engagement, economic impact, and more |
45K € per project |
30-09-2020 |
| Pan European |
OITB projects funded by H2020 |
For SMEs in MedTech looking to accelerate their work on the development of solutions to fight COVID-19 |
Services offered |
02-10-2020 |
International |
CEPI |
Accelerating vaccine development and manufacturing Phase II - vaccines striving for licensure/emergency authorization in 12-18 months or less and, to ensure the availability of sufficient doses by 2021 |
NA |
28-09-2020 |
